Skip to content

Midazolam Sedation for Neonatal Lumbar Puncture

Midazolam Sedation for Neonatal Lumbar Puncture in the Emergency Department: A Randomized Controlled Trial

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00942539
Enrollment
12
Registered
2009-07-21
Start date
2009-07-31
Completion date
2011-07-31
Last updated
2014-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain

Keywords

Neonates

Brief summary

Lumbar puncture is one of the most common painful procedures performed on neonates in the Emergency Department (ED). The investigators will study in a randomized controlled trial, the efficacy of intravenous administration of a single dose of Midazolam in reducing pain and anxiety in neonates undergoing lumbar puncture in the ED, as well as the rate of adverse sedation reactions. The investigators hypothesize that compared with placebo, single dose Midazolam would significantly decrease pain and anxiety and will have low rate of adverse reactions.

Interventions

DRUGMidazolam

Intravenous infusion of 0.05 mg/kg of Midalolam

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Days to 30 Days
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) score I, II * Post natal age ≤ 30 days * Fasting of at least 2 hours before the procedure

Exclusion criteria

* American Society of Anesthesiologists (ASA) score III or greater * Gestational age of 37 weeks or younger * Congenital disease or defect * Any medication provided by the caregiver prior ED admission * Fasting of less than 2 hours

Design outcomes

Primary

MeasureTime frame
The Simplified Neonatal Facial Coding System will be used for assessment of pain. Scoring will be composed from four specific facial actions (brow bulge, nasolabial furrow, eye squeeze, and open mouth) and the presence or absence of crying20 seconds prior lumbar puncture, during needle insertion, and 20 seconds post insertion

Secondary

MeasureTime frame
Physician's level of satisfaction from the procedural conditionsFive minutes post successful LP
LP Success rateFive minutes post successful LP
Adverse sedation reactionsDuring procedure and during recovery phase

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026